As on Wednesday, Mereo Biopharma Group Plc ADR (NASDAQ: MREO) started slowly as it slid -0.98% to $3.03, before settling in for the price of $3.06 at the close. Taking a more long-term approach, MREO posted a 52-week range of $2.53-$5.02.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -25.00%. Meanwhile, its Annual Earning per share during the time was 41.78%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -10.71%. This publicly-traded company’s shares outstanding now amounts to $154.73 million, simultaneously with a float of $142.11 million. The organization now has a market capitalization sitting at $468.83 million. At the time of writing, stock’s 50-day Moving Average stood at $3.67.
Mereo Biopharma Group Plc ADR (MREO) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Mereo Biopharma Group Plc ADR’s current insider ownership accounts for 8.16%, in contrast to 62.54% institutional ownership. According to the most recent insider trade that took place on Sep 13 ’24, this organization’s Chief Executive Officer sold 60,046 shares at the rate of 4.22, making the entire transaction reach 253,454 in total value, affecting insider ownership by 808,921. Preceding that transaction, on Sep 12 ’24, Company’s Chief Executive Officer sold 28,611 for 4.47, making the whole transaction’s value amount to 127,968. This particular insider is now the holder of 868,967 in total.
Mereo Biopharma Group Plc ADR (MREO) Earnings and Revenue Records
Mereo Biopharma Group Plc ADR’s EPS decrease for this current 12-month fiscal period is -10.71% and is forecasted to reach -0.04 in the upcoming year.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Trading Performance Indicators
Let’s observe the current performance indicators for Mereo Biopharma Group Plc ADR (MREO). It’s Quick Ratio in the last reported quarter now stands at 6.10. The Stock has managed to achieve an average true range (ATR) of 0.27.
Technical Analysis of Mereo Biopharma Group Plc ADR (MREO)
Through scrutinizing the latest numbers posted by the [Mereo Biopharma Group Plc ADR, MREO], it can be observed that its last 5-days Average volume of 1.76 million was better the volume of 1.44 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 21.91% While, its Average True Range was 0.28.
Raw Stochastic average of Mereo Biopharma Group Plc ADR (MREO) in the period of the previous 100 days is set at 5.69%, which indicates a major fall in contrast to 12.37% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 83.92% that was higher than 61.43% volatility it exhibited in the past 100-days period.
